BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 33540481)

  • 1. Pharmacology of HIV Cure: Site of Action.
    Devanathan AS; Cottrell ML
    Clin Pharmacol Ther; 2021 Apr; 109(4):841-855. PubMed ID: 33540481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Contributions of Clinical Pharmacology to HIV Cure Research.
    Fletcher CV; Dyavar SR; Acharya A; Byrareddy SN
    Clin Pharmacol Ther; 2021 Aug; 110(2):334-345. PubMed ID: 33763860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combating the HIV reservoirs.
    van Marle G; Church DL; van der Meer F; Gill MJ
    Biotechnol Genet Eng Rev; 2018 Apr; 34(1):76-89. PubMed ID: 29781356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eradication of HIV from Tissue Reservoirs: Challenges for the Cure.
    Rose R; Nolan DJ; Maidji E; Stoddart CA; Singer EJ; Lamers SL; McGrath MS
    AIDS Res Hum Retroviruses; 2018 Jan; 34(1):3-8. PubMed ID: 28691499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
    Pierson T; McArthur J; Siliciano RF
    Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotechnology approaches to eradicating HIV reservoirs.
    Cao S; Woodrow KA
    Eur J Pharm Biopharm; 2019 May; 138():48-63. PubMed ID: 29879528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Biology of the HIV-1 Latent Reservoir and Implications for Cure Strategies.
    Cohn LB; Chomont N; Deeks SG
    Cell Host Microbe; 2020 Apr; 27(4):519-530. PubMed ID: 32272077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the Central Nervous System Reservoir a Hurdle for an HIV Cure?
    Mohammadzadeh N; Chomont N; Estaquier J; Cohen EA; Power C
    Viruses; 2023 Dec; 15(12):. PubMed ID: 38140626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Importance of Tissue Sanctuaries and Cellular Reservoirs of HIV-1.
    Kalada W; Cory TJ
    Curr HIV Res; 2022 Aug; 20(2):102-110. PubMed ID: 34961449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Review of Current Strategies Towards the Elimination of Latent HIV-1 and Subsequent HIV-1 Cure.
    Maina EK; Adan AA; Mureithi H; Muriuki J; Lwembe RM
    Curr HIV Res; 2021; 19(1):14-26. PubMed ID: 32819259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VIP-SPOT: an Innovative Assay To Quantify the Productive HIV-1 Reservoir in the Monitoring of Cure Strategies.
    Puertas MC; Bayón-Gil Á; Garcia-Guerrero MC; Salgado M; Urrea V; Morón-López S; Peña R; Jiménez-Moyano E; Clotet B; Prado JG; Martinez-Picado J
    mBio; 2021 Jun; 12(3):e0056021. PubMed ID: 34154408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 Reservoirs During Suppressive Therapy.
    Barton K; Winckelmann A; Palmer S
    Trends Microbiol; 2016 May; 24(5):345-355. PubMed ID: 26875617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mathematical Models of HIV Latency.
    Hill AL
    Curr Top Microbiol Immunol; 2018; 417():131-156. PubMed ID: 29164341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Immunodeficiency Virus 1 (HIV-1): Viral Latency, the Reservoir, and the Cure.
    Ventura JD
    Yale J Biol Med; 2020 Sep; 93(4):549-560. PubMed ID: 33005119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current and Future Therapeutic Strategies for Lentiviral Eradication from Macrophage Reservoirs.
    Peterson TA; MacLean AG
    J Neuroimmune Pharmacol; 2019 Mar; 14(1):68-93. PubMed ID: 30317409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review: Influence of ART on HIV genetics.
    Simonetti FR; Kearney MF
    Curr Opin HIV AIDS; 2015 Jan; 10(1):49-54. PubMed ID: 25389802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maraviroc Is Associated with Latent HIV-1 Reactivation through NF-κB Activation in Resting CD4
    Madrid-Elena N; García-Bermejo ML; Serrano-Villar S; Díaz-de Santiago A; Sastre B; Gutiérrez C; Dronda F; Coronel Díaz M; Domínguez E; López-Huertas MR; Hernández-Novoa B; Moreno S
    J Virol; 2018 May; 92(9):. PubMed ID: 29444937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV reservoirs as obstacles and opportunities for an HIV cure.
    Chun TW; Moir S; Fauci AS
    Nat Immunol; 2015 Jun; 16(6):584-9. PubMed ID: 25990814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of latency reversal agents in the cure of HIV: A review of current data.
    Bashiri K; Rezaei N; Nasi M; Cossarizza A
    Immunol Lett; 2018 Apr; 196():135-139. PubMed ID: 29427743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding HIV compartments and reservoirs.
    Svicher V; Ceccherini-Silberstein F; Antinori A; Aquaro S; Perno CF
    Curr HIV/AIDS Rep; 2014 Jun; 11(2):186-94. PubMed ID: 24729094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.